1. Home
  2. GDOT vs OCS Comparison

GDOT vs OCS Comparison

Compare GDOT & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Dot Corporation $0.001 par value

GDOT

Green Dot Corporation $0.001 par value

N/A

Current Price

$12.37

Market Cap

750.5M

Sector

Finance

ML Signal

N/A

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

N/A

Current Price

$8.76

Market Cap

732.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDOT
OCS
Founded
1999
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
750.5M
732.4M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
GDOT
OCS
Price
$12.37
$8.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$16.13
★ $36.37
AVG Volume (30 Days)
★ 334.7K
183.9K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ 0.33
N/A
Revenue
★ $2,080,491,000.00
N/A
Revenue This Year
$15.22
N/A
Revenue Next Year
$6.73
$365.20
P/E Ratio
$37.39
★ N/A
Revenue Growth
★ 20.69
N/A
52 Week Low
$10.10
$9.00
52 Week High
$13.75
$34.48

Technical Indicators

Market Signals
Indicator
GDOT
OCS
Relative Strength Index (RSI) 28.64 28.67
Support Level $11.95 N/A
Resistance Level $12.61 $10.84
Average True Range (ATR) 0.25 0.49
MACD -0.09 -0.06
Stochastic Oscillator 42.13 9.78

Price Performance

Historical Comparison
GDOT
OCS

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for todays workforce.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: